Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.

  title={Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.},
  author={Kevin Bonfield and Erica Amato and Tony Bankemper and Hannah Agard and Jeffrey Steller and James M Keeler and David Roy and Adam M. McCallum and Stefan Paula and Lili Ma},
  journal={Bioorganic \& medicinal chemistry},
  volume={20 8},

Figures and Tables from this paper

In vivo evaluation of the aromatase inhibition by 4-((1H-imidazol-1-yl) methyl)-2-(4-fluorophenyl)- 8-phenylquinoline

A new quinoline derivative with higher specificity and potency is introduced that can be considered as new lead for further investigation to explore the more potent and more selective AIs.

Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor

In this study, sixteen of benzimidazole-triazolothiadiazine derivatives have been synthesized and studied as potent aromatase inhibitors and tested for their anti-cancer properties against human breast cancer cell line (MCF-7).

Novel inhibitor discovery against aromatase through virtual screening and molecular dynamic simulation: a computational approach in drug design

Inhibition of aromatase (CYTP450) as a key enzyme in the estrogen biosynthesis could result in regression of estrogen-dependent tumors and even preventing the promotion of breast cancer. Although

Molecular Modeling Of Novel Non-Steroidal Aromatase Inhibitors Containing 1,2,4-Triazole

Computer-aided design of the high-affinity inhibitors of aromatase based on 1,2,4-triasole derivatives was performed by molecular modeling tools and these compounds were suggested to present good scaffolds for the development of novel effective drugs against breast cancer.

Comparison of the effects of nobiletin and letrozole on the activity and expression of aromatase in the MCF-7 breast cancer cell line.

It is shown for the first time that NOB decreases the activity and expression of aromatase at low concentrations in MCF-7 breast cancer cells.

Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.

An account of recent developments in the AI field from the perspective of the enzyme's structure-function relationships is presented.

3D-QSAR study of steroidal and azaheterocyclic human aromatase inhibitors using quantitative profile of protein–ligand interactions

3D-QSAR combined with quantitative profile of protein–ligand interactions was employed in the identification and characterization of critical steric and electronic features of aromatase-inhibitor complexes and the estimation of their quantitative contribution to inhibition potency.

Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity

It can be concluded that the lead compounds may be developed as potent aromatase inhibitor performing their further biological evaluation.



Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.

The design, synthesis, and biological evaluation of a novel series of 2-(4'-pyridylmethylmethyl)thioisoflavones are described as the first example of synthetic isoflavone-based aromatase inhibitors.

Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study.

The binding characteristics and the structure requirement for flavone and isoflavone phytoestrogens to inhibit human aromatase were obtained and these compounds were found to bind to the active site of aromat enzyme in an orientation in which rings A and C mimic rings D and C of the androgen substrate, respectively.

Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase.

The design, synthesis, and biological evaluation of a series of new aromatase (AR, CYP19) inhibitors bearing an imidazole ring linked to a 7-substituted coumarin scaffold at position 4 (or 3) are

Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity.

The results suggest that a new structural class of DASI for potential treatment of hormone-dependent breast cancer has been identified, and this is the first report of STS inhibition by an enantiopure nonsteroidal compound.

Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors.

The modeling of the aromatase inhibition data by Comparative Molecular Field Analysis (CoMFA/GOLPE 3D QSAR approach) led to the development of a PLS model with good fitting and predictive powers that enables a clear understanding of the nature and spatial location of the main interactions modulating the arom atase inhibitory potency.